Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network
2019 ◽
Vol 24
(5)
◽
pp. 554-556
2019 ◽
Vol 24
(5)
◽
pp. 546-553
◽
2015 ◽
Vol 3
(4)
◽
pp. 123-126
◽